Table 1.
General information of the enroll participants
| Parameters | Controls (n = 75) |
ACS (n = 118) |
P values |
|---|---|---|---|
| Age, years | 60.12 ± 8.26 | 58.81 ± 7.96 | 0.275 |
| BMI, kg/m2 | 25.80 ± 3.77 | 26.75 ± 4.07 | 0.107 |
| Gender, male, n (%) | 45 (60.00) | 68 (57.63) | 0.766 |
| Smoking, n (%) | 46 (61.33) | 64 (54.24) | 0.372 |
| SBP, mmHg | 127.71 (124.74, 130.68) | 129.69 (123.75, 136.62) | 0.070 |
| DBP, mmHg | 78.90 (72.91, 82.89) | 82.17 (77.22, 88.11) | 0.002 |
| LDL-C, mmol/L | 2.59 ± 0.54 | 2.81 ± 0.80 | 0.040 |
| HDL-C, mmol/L | 1.36 (1.02, 1.64) | 1.35 (0.89, 1.63) | 0.278 |
| TC, mmol/L | 3.99 ± 0.58 | 4.12 ± 0.44 | 0.068 |
| TG, mmol/L | 1.48 ± 0.23 | 1.53 ± 0.56 | 0.437 |
| Creatine, µmol/L | 67.76 (60.35, 77.85) | 73.77 (68.48, 78.39) | 0.029 |
| WBC, ×109/L | 6.68 ± 0.50 | 7.41 ± 0.71 | 0.000 |
| UREA, mmol/L | 4.92 ± 0.37 | 4.88 ± 0.51 | 0.586 |
| NT-proBNP, pg/mL | 36.60 ± 6.04 | 110.59 ± 36.51 | 0.000 |
| hs-CRP, mg/L | - | 5.97 ± 1.39 | - |
| cTnI, ng/mL | - | 1.13 (0.05, 2.17) | - |
| SYNTAX score | - | 28.90 ± 10.95 | - |
| Gensini score | - | 49.13 ± 26.49 | - |
| Culprit lesion, n (%) | |||
| Left main | 1 (0.85) | ||
| Left anterior descending | 42 (35.59) | ||
| Left circumflex | 29 (24.58) | ||
| Right | 46 (38.98) | ||
| Baseline stenosis (%) | 94.08 ± 3.87 | ||
| MVD, n (%) | 73 (61.86) | ||
| Stent diameter (mm) | 3.06 ± 0.48 | ||
| Stent length (mm) | 26.50 ± 4.47 | ||
| Aspirin/clopidogrel, n (%) | 18 (15.25) | ||
| ACE inhibitor/ARB, n (%) | 31 (26.27) | ||
| β-blocker, n (%) | 25 (21.19) | ||
| Calcium Channel blocker, n (%) | 12 (10.17) | ||
| Stain, n (%) | 18 (15.25) |
Note: ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; MVD, multivessel disease; TC, total cholesterol; TG, triglyceride; WBC, white blood cells; hs-CRP, high-sensitivity C-reactive protein; cTnI, cardiac troponin I; Date was presented as mean ± SD, or median (first quartile, third quartile), or N (%)